SIA "Lotos Pharma"Active
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedNo dividends were paid.
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 140 543 | 185 047 | 196 426 | 166 661 | 306 695 | 484 267 | 711 295 | 1 354 841 | 1 915 465 | 2 596 741 | 3 247 540 |
| Total non-current assets | 134 886 | 128 415 | 139 315 | 185 400 | 158 839 | 615 611 | 670 483 | 815 067 | 1 340 175 | 1 501 204 | 1 448 393 |
| Total assets | 275 429 | 313 462 | 335 741 | 352 061 | 465 534 | 1 099 878 | 1 381 778 | 2 169 908 | 3 255 640 | 4 097 945 | 4 695 933 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 77 315 | 122 989 | 111 007 | 130 776 | 157 136 | 264 368 | 449 185 | 485 697 | 485 855 | 556 397 | 892 288 |
| Non-current liabilities | 143 487 | 126 300 | 104 923 | 79 115 | 118 995 | 448 737 | 328 849 | 328 752 | 702 975 | 770 163 | 583 636 |
| Total liabilities | 220 802 | 249 289 | 215 930 | 209 891 | 276 131 | 713 105 | 778 034 | 814 449 | 1 188 830 | 1 326 560 | 1 475 924 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 32 615 | 9484 | 55 638 | 22 359 | 103 534 | 193 627 | 216 971 | 751 715 | 711 351 | 766 708 | 386 107 |
| Total equity | 54 627 | 64 173 | 119 811 | 142 170 | 189 403 | 386 773 | 603 744 | 1 355 459 | 2 066 810 | 2 771 385 | 3 220 009 |
| Income statement | |||||||||||
| Sales revenue | 402 854 | 665 637 | 764 561 | 755 420 | 1 167 395 | 1 758 074 | 2 339 011 | 3 489 413 | 4 185 403 | 4 486 102 | 5 681 480 |
| Operating profit | 33 256 | 12 089 | 63 150 | 24 864 | 106 554 | 200 446 | 236 648 | 772 813 | 753 568 | 831 043 | 432 204 |
| Profit before income tax | 32 689 | 9484 | 60 571 | 22 369 | 103 534 | 193 646 | 216 971 | 751 865 | 713 744 | 767 412 | 386 333 |
| Profit for the reporting year | 32 615 | 9484 | 55 638 | 22 359 | 103 534 | 193 627 | 216 971 | 751 715 | 711 351 | 766 708 | 386 107 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 3 | 5 | 5 | 7 | 14 | 17 | 22 | 28 | 31 | 34 | 37 |
| Calculated dividend | — | 0 | 0 | 0 | 56 301 | 0 | 0 | 0 | 0 | 62 133 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA "Lotos Pharma"
Overview
SIA "Lotos Pharma" (reg. no. 40103638962) is a limited liability company. The company was registered in 2013 and has been in the register for 13 years. Registered address: Mārupes nov., Mārupe, Plieņciema iela 16.
Financial results
Revenue in 2025 was 5 681 480 €, up 26,6% on the previous year (4 486 102 €). From 2015 to 2025, revenue grew by an average of 30,3% per year. This is the company's highest revenue among the published years (2015–2025). Net profit for 2025 was 386 107 € (6,8% of revenue). The company was profitable in all 11 published years. In 2025 the company had 37 employees (34 a year earlier). Revenue per employee was 153 554 €. At the end of 2025, total assets were 4 695 933 € and equity 3 220 009 € (68,6% of assets).
Management and owners
The company has one board member. The sole owner of the company is a private individual. The company holds a stake in one other active Latvian company.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 02.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.